结核病实用随机试验的指导原则
综述提出结核病实用随机试验的指导原则,基于PRECIS-2框架讨论入组标准、招募、场所、照护组织、依从性支持、结局、随访、主要分析、数据收集与监查。实用试验应通过宽泛纳入标准、融入常规卫生系统和灵活实施方式最大化外推性,同时维持参与者安全与数据可靠性标准。
要点
- 实用试验应宽泛纳入并融入常规卫生系统以提高外推性。
- 设计需兼顾个体随机与整群随机,并明确结局定义。
- 采用风险相称的监查和精简数据收集以保障数据可靠性。
核心结论
- 采用所提指导原则可改善真实世界证据生成,促进有效结核病治疗的全球实施。
主要发现
- 实用试验应通过宽泛纳入标准、融入常规卫生系统和灵活实施方式最大化外推性。
- 需同时维持参与者安全和数据可靠性的适当标准。
关键数值与推荐
- 指导原则涵盖入组标准、招募、场所、照护组织、依从性支持、结局、随访、主要分析、数据收集与监查。
- 讨论了个体随机和整群随机设计、结局定义、风险相称监查和精简数据收集的考量。
临床怎么用
- 在常规照护条件下评估结核病治疗的有效性、安全性和耐受性,为实践指南提供信息并促进采纳。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tuberculosis remains a major global health challenge, despite recent advances in drug and regimen development. Pragmatic randomised trials are needed to evaluate the effectiveness, safety, and tolerability of new tuberculosis treatments under routine care conditions to appropriately inform practice guidelines and facilitate uptake. In this Review, we propose guiding principles for pragmatic tuberculosis treatment trials. Using the PRECIS-2 framework, we address eligibility, recruitment, setting, organisation of care, adherence support, outcomes, follow-up, primary analysis, data collection, and monitoring. Pragmatic trials should maximise generalisability through broad inclusion criteria, integration within routine health systems, and flexible delivery approaches while maintaining appropriate standards for participant safety and data reliability. We discuss considerations for individually randomised and cluster-randomised designs, outcome definitions, risk-proportionate monitoring, and streamlined data collection. Adoption of these principles will improve the generation of real-world evidence and facilitate global implementation of effective tuberculosis treatments.
引用
- Phillips PPJ, Schumacher SG, Cassino C, et al. Guiding principles for pragmatic randomised trials of tuberculosis treatments. Lancet Infect Dis. 2026. PMID: 42600623. doi:10.1016/S1473-3099(26)00359-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。